Category: 282734-37-6

On December 7, 2003, Tabanella, Stefania; Valancogne, Ingrid; Jackson, Richard F. W. published an article.Application In Synthesis of (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-bromopyridin-2-yl)propanoic acid The title of the article was Preparation of enantiomerically pure pyridyl amino acids from serine. And the article contained the following:

A range of substituted pyridyl amino acids have been prepared by palladium catalyzed cross-coupling of serine-derived organozinc reagents with differently substituted halopyridines. Following this procedure a DMAP analog has been synthesized and used as a building block in the preparation of two related tripeptides, which have been tested as catalysts in the kinetic resolution of trans-2-(N-acetylamino)cyclohexan-1-ol, resulting in modest enantioselectivity. The experimental process involved the reaction of (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-bromopyridin-2-yl)propanoic acid(cas: 282734-37-6).Application In Synthesis of (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-bromopyridin-2-yl)propanoic acid

The Article related to pyridyl amino acid preparation cross coupling organozinc serine, kinetic resolution catalyst pyridyl amino acid, Amino Acids, Peptides, and Proteins: Amino Acids and other aspects.Application In Synthesis of (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-bromopyridin-2-yl)propanoic acid

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

On April 30, 2000, Hoffmann, Reinhard W.; Caturla, Francisco; Lazaro, Miguel A.; Framery, Eric; Carmen Bernabeu, M.; Valancogne, Ingrid; Montalbetti, Christian A. G. N. published an article.Formula: C23H19BrN2O4 The title of the article was Conformational analysis of 4-amido-2,4-dimethylbutyric acid derivatives. And the article contained the following:

Several protected 4-amido-2,4-dimethylbutyrates were prepared Both, syn- and anti-4-amido-2,4-dimethylbutyric acid derivatives were found to populate a conformation in which the amido group is gauche to the main chain of the mol. In the anti series, a single conformation predominates, in which the acid carbonyl group is also gauche to the main chain. In the syn series, two local conformers prevail about the C(2)-C(3) bond. The experimental process involved the reaction of (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-bromopyridin-2-yl)propanoic acid(cas: 282734-37-6).Formula: C23H19BrN2O4

The Article related to amidomethylbutyrate preparation conformation, butyrate amido methyl preparation conformation, Amino Acids, Peptides, and Proteins: Amino Acids and other aspects.Formula: C23H19BrN2O4

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

On January 28, 2021, Cuthbertson, Alan; Boehnke, Niels published a patent.HPLC of Formula: 282734-37-6 The title of the patent was Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancer. And the patent contained the following:

The invention is related to the preparation of compounds I [n = 1-3; R1-4 = OH or Q; Q = a tissue-targeting moiety selected from the group consisting of poly- and oligopeptides, proteins, DNA and RNA fragments, aptamers polyclonal or monoclonal antibodies, and a mixture of proteins or fragments or constructs of protein] their stereoisomers, hydrates, solvates and salts, and targeted radiopharmaceuticals, pharmaceutical compositions and combinations comprising them and their use for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of soft tissue diseases, as a sole agent or in combination with other active ingredients. The experimental process involved the reaction of (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-bromopyridin-2-yl)propanoic acid(cas: 282734-37-6).HPLC of Formula: 282734-37-6

The Article related to peptide chelator conjugate preparation antitumor prostate cancer, preparation peptide chelator thorium 227 her2 fap psma conjugate, prostate specific membrane antigen carboxy hopo thorium 227 conjugate, targeted radiopharmaceutical prostate cancer and other aspects.HPLC of Formula: 282734-37-6

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

On January 28, 2021, Cuthbertson, Alan; Boehnke, Niels published a patent.HPLC of Formula: 282734-37-6 The title of the patent was Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancer. And the patent contained the following:

The invention is related to the preparation of compounds I [n = 1-3; R1-4 = OH or Q; Q = a tissue-targeting moiety selected from the group consisting of poly- and oligopeptides, proteins, DNA and RNA fragments, aptamers polyclonal or monoclonal antibodies, and a mixture of proteins or fragments or constructs of protein] their stereoisomers, hydrates, solvates and salts, and targeted radiopharmaceuticals, pharmaceutical compositions and combinations comprising them and their use for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of soft tissue diseases, as a sole agent or in combination with other active ingredients. The experimental process involved the reaction of (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-bromopyridin-2-yl)propanoic acid(cas: 282734-37-6).HPLC of Formula: 282734-37-6

The Article related to peptide chelator conjugate preparation antitumor prostate cancer, preparation peptide chelator thorium 227 her2 fap psma conjugate, prostate specific membrane antigen carboxy hopo thorium 227 conjugate, targeted radiopharmaceutical prostate cancer and other aspects.HPLC of Formula: 282734-37-6

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem